News Conference News ISC 2026 Loberamisal Scores a Rare Win for Stroke Neuroprotection Todd Neale February 12, 2026
News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
News Conference News ISC 2026 FASTEST Hints at Benefits of Hemostatic Therapy for Acute ICH in Select Groups Todd Neale February 05, 2026
News Daily News AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline Todd Neale January 29, 2026
News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION Todd Neale December 16, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2025 Caitlin E. Cox December 01, 2025
News Daily News Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients Caitlin E. Cox October 16, 2025
News Daily News Risk Factors Present in Nearly All Patients Who Develop CVD Michael O'Riordan October 02, 2025
News Daily News Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions L.A. McKeown September 22, 2025
News Conference News ESC 2025 Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF Michael O'Riordan August 29, 2025
News Daily News HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke Todd Neale August 11, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2025 Caitlin E. Cox July 31, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Conference News SCCT 2025 AI-QCT Possibly Lessens Gap Between Ideal vs Actual Care for Patients at Risk of ASCVD Yael L. Maxwell July 22, 2025
News Daily News Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board Michael O'Riordan June 25, 2025
News Daily News Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN Yael L. Maxwell April 29, 2025
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025